2014 Transcatheter Cardiovascular Therapeutics (TCT) Innovation Award

At the 2014 Transcatheter Cardiovascular Therapeutics (TCT) Conference Qool Therapeutics won First Prize for the First Annual TCT Innovation Award.  Over 50 companies applied for this prestigious award.  Qool Therapeutics is proud to be recognized for this honor.

“Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest and most important educational meeting specializing in interventional cardiovascular medicine. For over 25 years, TCT has been the center of cutting-edge educational content, showcasing the latest advances in current therapies and clinical research. We hope that our longstanding commitment to lifesaving innovation translates into improved patient care.” -http://www.crf.org/tct/about-tct/overview